Semeraro; Teresa

Patent Applications and Registrations

Patent applications and USPTO patent grants for Semeraro; Teresa.The latest application filed is for "dopamine d3 receptor antagonist compounds".

Company Profile

6.7.8

Semeraro; Teresa - Verona IT
Semeraro; Teresa - Verano IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Dopamine D.sub.3 receptor antagonist compounds Grant 10,654,842 - Cremonesi , et al.	2020-05-19
Substituted 3,6-diazabicyclo[3.2.0]heptanes Grant 10,584,135 - Cremonesi , et al.	2020-03-10
Dopamine D3 receptor antagonists having a morpholine moiety Grant 10,577,361 - Cremonesi , et al.	2020-03-03
Dopamine D3 Receptor Antagonist Compounds App 20190300514 - Cremonesi; Susanna ; et al.	2019-10-03
Dopamine D3 Receptor Antagonists Having A Bicyclo Moiety App 20190194225 - Cremonesi; Susanna ; et al.	2019-06-27
Substituted hexahydropyrrolo[3,4-b]pyrroles and hexahydrocyclopenta[c]pyrroles as dopamine receptor modulators Grant 10,273,244 - Micheli , et al.	2019-04-30
Dopamine D3 Receptor Antagonists Having A Morpholine Moiety App 20180297990 - Cremonesi; Susana ; et al.	2018-10-18
Dopamine D3 Receptor Antagonists Having A Bicyclo Moiety App 20180222918 - Cremonesi; Susanna ; et al.	2018-08-09
Dopamine D3 receptor antagonist compounds Grant 10,000,477 - Cremonesi , et al. June 19, 2	2018-06-19
N-(hetero)aryl-substituted heteroyclic derivatives useful for the treatment of diseases or conditions related to the central nervous system Grant 9,920,053 - Cremonesi , et al. March 20, 2	2018-03-20
Spirocyclic derivatives Grant 9,908,897 - Cremonesi , et al. March 6, 2	2018-03-06
Dopamine D3 Receptor Antagonist Compounds App 20170334895 - Cremonesi; Susanna ; et al.	2017-11-23
2-[bis(4-fluorophenyl)methyl]-2,7-diazaspiro[4.5]decan-10-one Derivatives And Related Compounds As Inhibitors Of The Human Dopamine-active-transporter (dat) Protein For The Treatment Of E.g. Attention Deficit Disorder (add) App 20170260185 - SEMERARO; Teresa ; et al.	2017-09-14
N-(hetero)aryl-substituted Heteroyclic Derivatives Useful For The Treatment Of Diseases Or Conditions Related To The Central Nervous System App 20170253592 - CREMONESI; Susanna ; et al.	2017-09-07
Spirocyclic derivatives App 20170253615 - CREMONESI; Susanna ; et al.	2017-09-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.